Fertility | Jotup

Studies Indicate Environmental Factors Can Impact Urologic Health

Retrieved on:

Friday, May 3, 2024

Population health, Drinking water, Risk, Tissue, Pesticide, American Urological Association, Abstract (summary), Abstract, NYU Langone Health, Fertility, Research, Prostate cancer, Urology, Bladder cancer, SAN, Agriculture

Researchers will present environmental and urological health study findings in San Antonio, Texas, from May 3 to 6.

Key Points:

Researchers will present environmental and urological health study findings in San Antonio, Texas, from May 3 to 6.
Stacy Loeb, MD, Urology and Population Health professor at NYU Langone Health, moderated a virtual press session with the abstract authors, providing key insights into their research.
“It’s great that these studies are happening so we can get a better sense of how some of these environmental factors may affect things like fertility and urological cancer risk,” said Dr. Loeb.
It sounds like, in these cases, more studies are needed to follow up on these findings on an individual level.”
The following abstracts are covered in the moderated panel:

Redfin Report: The Pool of People Taking Out Mortgages In America Is Becoming Less White

Retrieved on:

Friday, May 3, 2024

Residential Building & Real Estate, Fintech, Construction & Property, Professional Services, Brookings Institution, Bangladesh Technical Education Board, Fertility, Data, HMDA, Home Mortgage Disclosure Act, Death, Ageing, COVID-19, Growth, Real estate

While that’s a far higher share than any other group, it’s down from 64% in 2022 and 70.4% in 2018.

Key Points:

While that’s a far higher share than any other group, it’s down from 64% in 2022 and 70.4% in 2018.
Meanwhile, the share of new mortgages taken out by Hispanic buyers increased to 14% in 2023 from 12.6% in 2022 and 11% in 2018.
“The pool of homebuyers taking out mortgages is becoming less white because America is becoming more diverse, and many people of color are in their prime homebuying years,” said Redfin Senior Economist Elijah de la Campa.
White people took out 1,582,643 mortgages in 2023, down 22.1% from a year earlier and down 31.3% from 2018.

National Women’s Law Center and Law Firm Emery Celli Brinckerhoff Abady Ward & Maazel, LLP Announce Settlement of Class Action Lawsuit Against Aetna Over LGBTQ+ Fertility Coverage

Retrieved on:

Friday, May 3, 2024

v. Aetna , filed in September 2021, the plaintiffs challenged Aetna’s definition of infertility, alleging it led to unequal insurance coverage treatment for LGBTQ+ couples.

Key Points:

v. Aetna , filed in September 2021, the plaintiffs challenged Aetna’s definition of infertility, alleging it led to unequal insurance coverage treatment for LGBTQ+ couples.
Aetna will re-process eligible insurance claims to reimburse class members for their out-of-pocket artificial insemination cycles, up to the plan limits.
Aetna will also separately pay all the costs of the administrator and special master who will allocate the common fund.
If you believe you are in the class of individuals covered by this settlement, please visit this page or contact: 1-800-205-6861.

Second Opinion Expert Announces OC FERTILITY® + OC BIOGENIX® To Join Its Panel To Provide Expert Second Opinions.

Retrieved on:

Saturday, May 4, 2024

Patient, PCOS, PGT, Infertility, Freezing, Anesthesiology, SOE, ICSI, Fertility, Genetic testing, IVF, Embryology, MPH, DANA, OC, IUI, FACOG, Semen analysis

DANA POINT, Calif., May 4, 2024 /PRNewswire-PRWeb/ -- SecondOpinionExpert, Inc. (SOE), a leading healthcare technology company, announced today that OC Fertility® + OC Biogenix® located in Newport Beach, Orange County, California will join SOE's expert panel to provide second opinions for fertility cases.

Key Points:

DANA POINT, Calif., May 4, 2024 /PRNewswire-PRWeb/ -- SecondOpinionExpert, Inc. (SOE), a leading healthcare technology company, announced today that OC Fertility® + OC Biogenix® located in Newport Beach, Orange County, California will join SOE's expert panel to provide second opinions for fertility cases.
"We are honored to join the SOE panel to provide our expertise for challenging fertility cases and excited to leverage SOE's powerful second opinion platform as another way for us to help families," said Dr. Sharon Moayeri, founder and medical director of OC Fertility® + OC Biogenix®.
OC Fertility® + OC Biogenix® is a leading Southern California medical practice providing the best in fertility care and advanced laboratory services.
OC Fertility® + OC Biogenix®'s expert team features: Board-certified specialists, fellowship-trained in reproductive endocrinology, infertility, embryology, and anesthesiology, advanced public health education & advocacy and patient-centered, trauma-informed care.

SenesTech Launches Evolve™ Mouse

Retrieved on:

Thursday, May 2, 2024

Mouse, SNES, Reproduction, Health, Infestation, Fertility, Environment, SenesTech, Poison, Pest control, Rat, Hunting

PHOENIX, May 2, 2024 /PRNewswire/ -- SenesTech, Inc. (Nasdaq: SNES; "SenesTech" or the "Company"), the leader in fertility control to manage animal pest populations, today announces that the Company has launched Evolve™ Mouse, utilizing a breakthrough fertility control solution, for the control of mouse infestations. Evolve Mouse is designated as a 'minimum risk' product by the U.S. Environmental Protection Agency, posing little to no risk to human health and the environment. The Company will be accepting orders as of Monday, May 6th, for shipment on or before May 15th.

Key Points:

PHOENIX, May 2, 2024 /PRNewswire/ -- SenesTech, Inc. (Nasdaq: SNES; "SenesTech" or the "Company"), the leader in fertility control to manage animal pest populations, today announces that the Company has launched Evolve™ Mouse, utilizing a breakthrough fertility control solution, for the control of mouse infestations.
Evolve Mouse will initially be available to consumers and professionals in 1.5 and 3 lb.
"Evolve Mouse is a much needed extension of the Evolve product line into an underserved market.
"Evolve Mouse isn't just about control—it's about reclaiming our spaces from the relentless invasion of mice."

Smart Mouthguards and Anti-Aging Lights - IDTechEx Explores Wearables

Retrieved on:

Tuesday, April 30, 2024

Sport is a large sector for the wearables market, but it gets better than simply wearing a smartwatch.

Key Points:

Sport is a large sector for the wearables market, but it gets better than simply wearing a smartwatch.
Contact sports such as rugby have opened a gap in the market for smart mouthguards .
In-ear devices are also a future possibility for football players, as they are more discreet, and the use of mouthguards might not be suitable.
For more information on VR and AR headsets, see the IDTechEx report, ' Virtual Reality & Augmented Reality Headsets 2023-2033: Technologies, Players, and Markets' .

Smart Mouthguards and Anti-Aging Lights - IDTechEx Explores Wearables

Retrieved on:

Tuesday, April 30, 2024

Sport is a large sector for the wearables market, but it gets better than simply wearing a smartwatch.

Key Points:

Sport is a large sector for the wearables market, but it gets better than simply wearing a smartwatch.
Contact sports such as rugby have opened a gap in the market for smart mouthguards .
In-ear devices are also a future possibility for football players, as they are more discreet, and the use of mouthguards might not be suitable.
For more information on VR and AR headsets, see the IDTechEx report, ' Virtual Reality & Augmented Reality Headsets 2023-2033: Technologies, Players, and Markets' .

Health-E Commerce® shares 5 ways to use FSA or HSA funds to support women's health

Retrieved on:

Monday, April 29, 2024

DALLAS, April 29, 2024 /PRNewswire-PRWeb/ -- The hormonal changes that women experience throughout their lives put them at increased risk for serious or chronic health conditions like diabetes, stroke, obesity, and even breast cancer. Fortunately, managing everyday health can go a long way toward preventing the onset of these conditions. Now, as Women's Health Month kicks off, Health-E Commerce®, parent brand to FSA Store® and HSA Store®, is educating women who are enrolled in a flexible spending account (FSA) or health savings account (HSA) about how they can protect their health and manage the effects of hormonal changes – while also saving money by using their tax-free healthcare funds.

Key Points:

There are numerous products and services available to support women on their health journeys.
FSA Store and HSA Store are proud to offer a wide variety of women's health products and a convenient, guaranteed-eligible shopping experience.
FSA Store and HSA Store are proud to offer a wide variety of women's health products and a convenient, guaranteed-eligible shopping experience."
To learn more about using tax-free funds to support women's health, visit the searchable eligibility lists at FSA Store or HSA Store .

Boston IVF Welcomes Dr. Josette Dawkins to its Springfield Fertility Center, Further Enhancing Access to Expert Reproductive Care in Western Massachusetts

Retrieved on:

Monday, April 29, 2024

SPRINGFIELD, Mass., April 29, 2024 /PRNewswire-PRWeb/ -- Boston IVF, one of the world's most experienced fertility treatment providers, which has assisted in over 150,000 babies born since 1986, is pleased to announce the addition of reproductive endocrinologist, Dr. Josette Dawkins, MD to its Springfield, MA fertility center and team.

Key Points:

The addition of Dr. Josette Dawkins to Boston IVF and its fertility clinic in Springfield enriches the accessibility of timely reproductive care for individuals seeking to start a family.
She joins Boston IVF from Baystate Reproductive Medicine in Springfield, MA – where she served as its Medical Director.
"We are thrilled to extend a warm welcome to Dr. Josette Dawkins as she joins our esteemed Boston IVF team in Springfield, Massachusetts," expressed David Stern, CEO of Boston IVF.
"I am honored to become part of the respected team at Boston IVF," said Dr. Josette Dawkins.

Anti-Mullerian Hormone Test Market Projected to Reach $586.48 million by 2030 - Exclusive Report by 360iResearch

Retrieved on:

Saturday, April 27, 2024

Anti-mullerian hormone (AMH) tests are critical in assessing a woman's remaining egg count, potential fertility, and the health of her ovaries.

Key Points:

Anti-mullerian hormone (AMH) tests are critical in assessing a woman's remaining egg count, potential fertility, and the health of her ovaries.
A key tool in identifying PCOS is the Anti-Müllerian hormone (AMH) test, which measures the levels of AMH produced by ovarian follicles.
We proudly unveil ThinkMi, a cutting-edge AI product designed to transform how businesses interact with the Anti-Mullerian Hormone Test Market.
"Dive into the Anti-Mullerian Hormone Test Market Landscape: Explore 195 Pages of Insights, 368 Tables, and 24 Figures"